Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
refractory/recurrent central nervous system lymphoma, refractory or recurrent, central nervous system lymphoma, diffuse large b cell lymphoma, car-nk, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 899860
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.